White Blood Cells Flashcards
Neutropenia/Agranulocytosis
Pathogenesis (6) Clinical Feature
Agranulocytosis is clinically significant neutropenia*
Inadequate Granulopoiesis:
Suppression of stem cells
Drug suppression of precursors (most common)
Ineffective hematopoiesis
Accelerated Destruction:
Immune mediated injury
Splenomegaly (sequestration)
Increased peripheral utilization
Infections causing mucosal ulcerations
Leukocytosis
Etiologies (4) Types with Causes (5)
Increased production in marrow (chronic disorders)
Increased release from marrow stores (infection)
Decreased margination (exercise)
Decreased extravasation into tissues (glucocorticoids)
Neutrophilic: Acute bacterial infection, inflammation
Eosinophilic: Allergies, Autoimmune Disorders
Basophilic: myeloproliferative disorders
Monocytosis: Chronic infections
Lymphocytosis: Chronic infections, Viral infections
Lymphadenitis Acute Etiologies (4) Chronic Morphology (4)
Cervical: Infections of teeth or tonsils
Axillary/Inguinal: Extremity infections
Mesenteric: Acute appendicitis
Generalized: Systemic viral infections and bacteremia
Follicular Hyperplasia (humoral germinal centers) Tingible Body Macrophages seen between GC's Paracortical Hyperplasia (T cell response) Sinus Histiocytosis (sinuses draining cancer)
Hemophagocytic Lymphohistiocytosis
Pathogenesis (4) Labs (4) Clinical Features (3) Treatment (2)
Activation of macrophages and CD8+ CTLs
Macrophages phagocytose bone marrow RBC progenitors
Familial forms caused by decreased degranulation from CTLs and NK cells
Triggered by EBV infection
Elevated Ferritin and IL-2r
Anemia, Thrombocytopenia
Acute febrile illness
Hepatosplenomegaly (hepatitis)
Disseminated Intravascular Coagulation
Treat with immunosuppression and mild chemotherapy
White Cell Neoplasias
Etiologic Factors
Mutations (4) Viruses (3) Others (4)
Chromosomal translocations:
Help malignant cells proliferate and survive
Create oncoproteins useful for protection and growth
Proto-oncogenes made during receptor rearrangements
Human T cell Leukemia Virus 1 (HTLV-1)
EBV
HHV-8
Smoking (acute myeloid leukemia)
Iatrogenic (radiation/chemo)
Chronic Inflammation (H. pylori)
Inherited Genes
Leukemia vs Lymphoma Definitions
Leukemia
Neoplasms with widespread involvement of bone marrow and peripheral blood
Lymphoma
Start as discrete tissue masses
Principles of Lymphoid Neoplasms (6)
All daughter cells of malignant progenitor share same antigen receptor genes (immunophenotype)
Most cells will appear to be at some point of B/T cell differentiation
Often associated with immune abnormalities
Neoplastic B and T cells will act similar to non-neoplastic
Hodgkin Lymphoma spread orderly
Non-Hodgkin Lymphoma spreads widely and unpredictably
Acute Lymphoblastic Leukemia/Lymphoma
B Cell ALL: Population, Mutations (3), Origin Site
T Cell ALL: Population, Mutation, Origin Site
Prognosis (2) Immunophenotype (3) Lymphoblast Morphology (3)
B Cell Acute Leukemia:
Most common cancer of Children**
t(12;21) translocations, RUNX1, ETV6 mutations
Hypercellular Bone marrow: causes pancytopenia
T Cell Acute Lymphoma
Adolescent males
NOTCH1 mutations
Thymus
Aggressive in both cases
Excellent prognosis with aggressive chemotherapy
TdT (+)
CD10/CD19/CD20 (+) (B Cell ALL)
CD1-CD8 (+) (T Cell ALL)
Small amount of cytoplasm
No granules
Condensed Chromatin
Acute Lymphoblastic Leukemia
Clinical Features (6)
Favorable (5) and Unfavorable (3) Prognostics
Abrupt onset of symptoms within weeks:
Anemia, Bleeding
CNS symptoms
Mass Effects: bone pain, General Lymphadenopathy, Hepatosplenomegaly, Testicle Enlargement
Favorable: Age > 2, Low WBC, Hyperdiploidy, Trisomies, t(12;21)
Unfavorable: Age < 2 or adolescent/adult, Peripheral Blasts > 100,000, t(9;22) Philadelphia gene (BCR-ABL)
Chronic Lymphocytic Leukemia and Small LL
Population (2) Genetics (4) Origin, Immunophenotype (4) Clinical Features (5) Morphology (2)
- CLL and SLL differ only in degree of lymphocytosis
- CLL is >5000
Most common leukemia in Adults Older Males (60s)
Deletions: 13q14.3, 11q, 17q
Trisomy 12q
Starts in Lymph Nodes
CD19
CD20
CD23
CD5
Asymptomatic at diagnosis Small Ig spike present in some patients Hypogammaglobulinemia Hemolytic anemia/Thrombocytopenia Progression to Diffuse Large B cell Lymphoma (poor prognosis)
Proliferation Centers** (T cell aggregates)
Smudge cells
Follicular Lymphoma
Prognosis (2) Origin, Genetics (2) Morphology (3) Immunophenotype (6) Clinical Features (3)
Most common indolent non-hodgkin lymphoma
Incurable, survival 7-9 years
Starts in Lymph Nodes
t(14;18) IGH-BCL2 translocation**
MLL2 mutations
Centrocytes (small cleaved cells)
Centroblasts
Peritrabecular lymphoid aggregates in bone marrow
CD10, CD19, CD20
surface Ig
BCL6
BCL2*
Painless generalized lymphadenopathy
Waxing and waning course
Possible histologic transformation to Diffuse Large B cell lymphoma
Diffuse Large B Cell Lymphoma
Population, Pathogenesis (2) Morphology (2) Immunophenotype (3) Clinical Features (2) Prognosis (2)
Subtypes (2) with Descriptions (2/2)
Most common Non-Hodgkin Lymphoma*
Older males (median age 60)
BCL6 dysregulation
Or BCL2 rearrangements t(14;18)
Diffuse growth pattern
Large cells with round/oval nuclei, appear vesicular
CD19, CD20, surface Ig
Rapidly enlarging mass at nodal/extranodal sites
Waldeyer ring involvement
Aggressive, death if untreated
About half cured with aggressive chemo
Immunodeficiency-associated LBCL:
Associated with HIV
Caused by EBV infection
Primary Effusion Lymphoma:
Pleural/Ascitic effusion associated with HIV
Caused by KSHV/HHV-8
Burkitt Lymphoma
Populations (2) Origin, Genetics (2) Morphology (4) Immunophenotype (5) Prognosis (2)
Subtypes: Endemic (3), HIV-Associated, Sporadic (2)
Children
Young adults
Germinal centers
Translocation of c-MYC onto Chromosome 8
High mitotic index
Apoptotic cells
Phagocytes with clear cytoplasm (Starry sky pattern)
Blue cytoplasm with multiple nuclei (if in marrow)
CD10, CD19, CD20, IgM, BCL6
Aggressive, fastest growing tumor in humans
Curable with intense chemotherapy
Endemic: EBV associated, jaw mass, involves viscera
HIV-associated: aggressive
Sporadic: mass in illeocecum and peritoneum
Plasma Cell Neoplasms (Dyscrasias)
Most Common, Diagnostic Factors with Descriptions (2) Common Immunophenotype (2)
Multiple Myeloma
M Component in blood (monoclonal Ig)
Bence Jones Proteins (free light chains in urine)
CD138 (syndecan-1)
CD56
Multiple Myeloma
Pathogenesis (3) Morphology (5) Clinical Features (5) Diagnostic Features (3) Genetic Prognostics (4)
Rearrangements of the IgH locus - Cyclin D1 mutations
IL-6 keeps myeloma cells alive
MIP1a upregulates RANKL, causes bone resorption
Rouleaux Formation** (red cells stuck together)
Punched out bone lesions** 1-4 cm
Plasmablasts, Flame cells, Mott cells
Inclusions: Fibrils, Crystalline rods
Russell or Dutcher bodies (globular inclusions)
**Multiple Lytic bone lesions (Pathologic Fx)
Hypercalcemia (neuro Sx)
Renal failure (from Bence Jones)
Amyloidosis (from Bence Jones)
**Recurrent bacterial infections (main cause of death)
Bone marrow shows >30% atypical plasma cells
> 3g M proteins in blood (usually IgG or IgA)
> 6g Bence Jones proteins
Cyclin D1 translocations, good
13q, 17p t(4;14), bad
Solitary Myeloma (Plasmacytoma)
Description and Prognosis
Osseous and Extraosseous
Single bone lesion
Inevitably progresses to mutliple myeloma (10-20 years)
Extraosseous lesions often in upper respiratory tract
Cured via excision
Smoldering Myeloma Clinical Description (2) and Prognosis
Asymptomatic multiple myeloma-like syndrome
Serum M protein greater than 3g
Often progresses to MM over 15 years
Monoclonal Gammopathy of Uncertain Significance Clinical Description (2) and Prognosis
*Most common plasma cell disorder
Asymptomatic multiple myeloma-like syndrome
Serum M protein less than 3g
Per year ~1% of patients develop multiple myeloma